{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:04:53Z","timestamp":1792796693998,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province, China","doi-asserted-by":"crossref","award":["2025JJ80579"],"award-info":[{"award-number":["2025JJ80579"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province, China","doi-asserted-by":"crossref","award":["2025JJ60615"],"award-info":[{"award-number":["2025JJ60615"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Changsha City, Hunan Province, China","award":["kq2502328"],"award-info":[{"award-number":["kq2502328"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02262-w","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:07:30Z","timestamp":1766149650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Construction and verification of a prognostic model for prostate cancer based on ribosome biogenesis-related genes"],"prefix":"10.1186","volume":"18","author":[{"given":"JiaWei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanHong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuHang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FaJun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuMing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZiJian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PeiMin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianJun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2262_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2262_CR2","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"2262_CR3","doi-asserted-by":"publisher","unstructured":"Ito K, Mori K, Kumar R, Sabnis RB, Lojanapiwat B, Kimura T et al. Global viewpoints: evolving epidemiology and treatment patterns of prostate cancer in Asia. BJU Int. Published online August 24, 2025. https:\/\/doi.org\/10.1111\/bju.16900.","DOI":"10.1111\/bju.16900"},{"issue":"3","key":"2262_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2262_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41585-021-00442-8","volume":"18","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. Epidemiology and genomics of prostate cancer in Asian men. Nat Rev Urol. 2021;18:282\u2013301.","journal-title":"Nat Rev Urol"},{"key":"2262_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4:877\u201392.","journal-title":"Eur Urol Oncol"},{"key":"2262_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg4132","volume":"14","author":"M Sawant","year":"2022","unstructured":"Sawant M, Mahajan K, Renganathan A, Weimholt C, Luo J, Kukshal V, et al. Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting. Sci Transl Med. 2022;14:eabg4132.","journal-title":"Sci Transl Med"},{"key":"2262_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","volume":"86","author":"D Tilki","year":"2024","unstructured":"Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2024;86:164\u201382.","journal-title":"Eur Urol"},{"key":"2262_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1122670","volume":"14","author":"W Zhu","year":"2023","unstructured":"Zhu W, Wu J, Huang J, Xiao D, Li F, Wu C, et al. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer. Front Immunol. 2023;14:1122670.","journal-title":"Front Immunol"},{"key":"2262_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1029069","volume":"13","author":"YL Vishweshwaraiah","year":"2022","unstructured":"Vishweshwaraiah YL, Dokholyan NV. mRNA vaccines for cancer immunotherapy. Front Immunol. 2022;13:1029069.","journal-title":"Front Immunol"},{"key":"2262_CR11","doi-asserted-by":"publisher","unstructured":"Bilusic M, McMahon S, Madan RA, Karzai F, Tsai YT, Donahue RN, et al. Phase I study of a multitargeted recombinant Ad5 PSA\/MUC-1\/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC). J Immunother Cancer. 2021;9(3):e002374. https:\/\/doi.org\/10.1136\/jitc-2021-002374.","DOI":"10.1136\/jitc-2021-002374"},{"key":"2262_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1615\/JEnvironPatholToxicolOncol.2021040339","volume":"41","author":"L Pang","year":"2022","unstructured":"Pang L, Ren F, Xu X, Fu L, Wang T, Guo Z. Construction and characterization of Cadherin 6 (CDH6)-targeting chimeric antigen receptor (CAR) modified T cells. J Environ Pathol Toxicol Oncol. 2022;41:55\u201371.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"2262_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084109","author":"MM Kgatle","year":"2021","unstructured":"Kgatle MM, Boshomane TMG, Lawal IO, Mokoala KMG, Mokgoro NP, Lourens N, et al. Immune checkpoints, inhibitors and radionuclides in prostate cancer: promising combinatorial therapy approach. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22084109.","journal-title":"Int J Mol Sci"},{"key":"2262_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1009634","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen L, Zheng Y, Jiang C, Yang C, Zhang L, Liang C. The established chemokine-related prognostic gene signature in prostate cancer: implications for anti-androgen and immunotherapies. Front Immunol. 2022;13:1009634.","journal-title":"Front Immunol"},{"key":"2262_CR15","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Cancer Res. 2022;82:2344\u201353.","journal-title":"Cancer Res"},{"key":"2262_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00728-8","volume":"6","author":"J Kang","year":"2021","unstructured":"Kang J, Brajanovski N, Chan KT, Xuan J, Pearson RB, Sanij E. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy. Signal Transduct Target Ther. 2021;6:323.","journal-title":"Signal Transduct Target Ther"},{"key":"2262_CR17","doi-asserted-by":"publisher","unstructured":"Cao P, Yang A, Li P, Xia X, Han Y, Zhou G et al. Genomic gain of RRS1RRS1 promotes hepatocellular carcinoma through reducing the RPL11-MDM2-p53 signaling. Sci Adv. 2021;7.Sci Adv. 2021;7(35):eabf4304. Published 2021 Aug 25. https:\/\/doi.org\/10.1126\/sciadv.abf4304.","DOI":"10.1126\/sciadv.abf4304"},{"key":"2262_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115496","author":"A Pecoraro","year":"2021","unstructured":"Pecoraro A, Pagano M, Russo G, Russo A. Ribosome biogenesis and cancer: overview on ribosomal proteins. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22115496.","journal-title":"Int J Mol Sci"},{"key":"2262_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112361","author":"S Nait Slimane","year":"2020","unstructured":"Nait Slimane S, Marcel V, Fenouil T, Catez F, Saurin JC, Bouvet P, et al. Ribosome biogenesis alterations in colorectal cancer. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9112361.","journal-title":"Cells"},{"key":"2262_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s12094-019-02229-1","volume":"22","author":"Z Binal","year":"2020","unstructured":"Binal Z, Acikgoz E, Kizilay F, Oktem G, Altay B. Cross-talk between ribosome biogenesis, translation, and mTOR in CD133\u2009+\u20094\/CD44\u2009+\u2009prostate cancer stem cells. Clin Transl Oncol. 2020;22:1040\u20138.","journal-title":"Clin Transl Oncol"},{"key":"2262_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.856580","volume":"12","author":"P Li","year":"2022","unstructured":"Li P, Shi Y, Guo M, Xu H, Zhan M, Wang Z, et al. MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression. Front Oncol. 2022;12:856580.","journal-title":"Front Oncol"},{"key":"2262_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae023","author":"Y Zang","year":"2024","unstructured":"Zang Y, Ran X, Yuan J, Wu H, Wang Y, Li H, et al. Genomic hallmarks and therapeutic targets of ribosome biogenesis in cancer. Brief Bioinform. 2024. https:\/\/doi.org\/10.1093\/bib\/bbae023.","journal-title":"Brief Bioinform"},{"key":"2262_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2262_CR24","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson EK, Zhang D, Reynolds RH, Garcia-Ruiz S, Ryten M. Ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics. 2022;38:3844\u20136.","journal-title":"Bioinformatics"},{"key":"2262_CR25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/bioinformatics\/btab806","volume":"38","author":"Z Gu","year":"2022","unstructured":"Gu Z, H\u00fcbschmann D. Make interactive complex heatmaps in R. Bioinformatics. 2022;38:1460\u20132.","journal-title":"Bioinformatics"},{"key":"2262_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-35","volume":"12","author":"H Chen","year":"2011","unstructured":"Chen H, Boutros PC. Venndiagram: a package for the generation of highly-customizable venn and Euler diagrams in R. BMC Bioinformatics. 2011;12:35.","journal-title":"BMC Bioinformatics"},{"key":"2262_CR27","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. Clusterprofiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"2262_CR28","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jso.27358","volume":"128","author":"J Lei","year":"2023","unstructured":"Lei J, Qu T, Cha L, Tian L, Qiu F, Guo W, et al. Clinicopathological characteristics of pheochromocytoma\/paraganglioma and screening of prognostic markers. J Surg Oncol. 2023;128:510\u20138.","journal-title":"J Surg Oncol"},{"key":"2262_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15609-5","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Lu F, Yin Y. Applying logistic LASSO regression for the diagnosis of atypical crohn\u2019s disease. Sci Rep. 2022;12:11340.","journal-title":"Sci Rep"},{"key":"2262_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1\u201322.","journal-title":"J Stat Softw"},{"key":"2262_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scog.2017.10.001","volume":"11","author":"IS Ramsay","year":"2018","unstructured":"Ramsay IS, Ma S, Fisher M, Loewy RL, Ragland JD, Niendam T, et al. Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophr Res Cogn. 2018;11:1\u20135.","journal-title":"Schizophr Res Cogn"},{"key":"2262_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337\u201344.","journal-title":"Biometrics"},{"key":"2262_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49034-z","volume":"13","author":"D Spari","year":"2023","unstructured":"Spari D, Zwicky SN, Yilmaz B, Salm L, Candinas D, Beldi G. Intestinal dysbiosis as an intraoperative predictor of septic complications: evidence from human surgical cohorts and preclinical models of peritoneal sepsis. Sci Rep. 2023;13:22921.","journal-title":"Sci Rep"},{"key":"2262_CR34","doi-asserted-by":"publisher","unstructured":"Sachs MC. PlotROC: A tool for plotting ROC curves. J Stat Softw. 2017;79:2. https:\/\/doi.org\/10.18637\/jss.v079.c02.","DOI":"10.18637\/jss.v079.c02"},{"key":"2262_CR35","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32:5381\u201397.","journal-title":"Stat Med"},{"key":"2262_CR36","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W Walter","year":"2015","unstructured":"Walter W, Sanchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31:2912\u20134.","journal-title":"Bioinformatics"},{"key":"2262_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"2262_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137.","journal-title":"Nat Methods"},{"key":"2262_CR39","doi-asserted-by":"crossref","unstructured":"Orifjon S, Jammatov J, Sousa C, Barros R, Vasconcelos O, Rodrigues P. Translation and adaptation of the adult developmental coordination Disorder\/Dyspraxia checklist (ADC) into Asian Uzbekistan. Sports (Basel). 2023;11.","DOI":"10.3390\/sports11070135"},{"key":"2262_CR40","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science"},{"key":"2262_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147755","volume":"888","author":"Y Hua","year":"2023","unstructured":"Hua Y, Xie D, Zhang Y, Wang M, Wen W, Sun J. Identification and analysis of key genes in adipose tissue for human obesity based on bioinformatics. Gene. 2023;888:147755.","journal-title":"Gene"},{"key":"2262_CR42","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.semcancer.2022.03.025","volume":"86","author":"W Li","year":"2022","unstructured":"Li W, Deng X, Chen J. RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. Semin Cancer Biol. 2022;86:664\u201377.","journal-title":"Semin Cancer Biol"},{"key":"2262_CR43","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173-80.","journal-title":"Lancet Oncol"},{"key":"2262_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103580","volume":"28","author":"JB Bertoldo","year":"2023","unstructured":"Bertoldo JB, Muller S, Huttelmaier S. RNA-binding proteins in cancer drug discovery. Drug Discov Today. 2023;28:103580.","journal-title":"Drug Discov Today"},{"key":"2262_CR45","doi-asserted-by":"publisher","unstructured":"He T, Cheng C, Qiao Y, Cho H, Young E, Mannan R et al. Development of an orally bioavailable mSWI\/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer. BioRxiv. 2024.Proc Natl Acad Sci U S A. 2024;121(15):e2322563121. https:\/\/doi.org\/10.1073\/pnas.2322563121.","DOI":"10.1073\/pnas.2322563121"},{"key":"2262_CR46","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1038\/s41467-020-19402-8","volume":"11","author":"TM Fernando","year":"2020","unstructured":"Fernando TM, Piskol R, Bainer R, Sokol ES, Trabucco SE, Zhang Q, et al. Functional characterization of SMARCA4SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients. Nat Commun. 2020;11:5551.","journal-title":"Nat Commun"},{"key":"2262_CR47","doi-asserted-by":"publisher","first-page":"216022","DOI":"10.1016\/j.canlet.2022.216022","volume":"554","author":"Y Tian","year":"2023","unstructured":"Tian Y, Xu L, Li X, Li H, Zhao M. SMARCA4SMARCA4: current status and future perspectives in non-small-cell lung cancer. Cancer Lett. 2023;554:216022.","journal-title":"Cancer Lett"},{"key":"2262_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07393-1","volume":"629","author":"L Xiao","year":"2024","unstructured":"Xiao L, Parolia A, Qiao Y, Bawa P, Eyunni S, Mannan R, et al. Author correction: Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer. Nature. 2024;629:E9.","journal-title":"Nature"},{"key":"2262_CR49","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1128\/MCB.20.6.2066-2074.2000","volume":"20","author":"A Tsuno","year":"2000","unstructured":"Tsuno A, Miyoshi K, Tsujii R, Miyakawa T, Mizuta K. RRS1RRS1, a conserved essential gene, encodes a novel regulatory protein required for ribosome biogenesis in Saccharomyces cerevisiae. Mol Cell Biol. 2000;20:2066\u201374.","journal-title":"Mol Cell Biol"},{"key":"2262_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/1078-0432.CCR-09-1423","volume":"16","author":"AT El Gammal","year":"2010","unstructured":"El Gammal AT, Bruchmann M, Zustin J, Isbarn H, Hellwinkel OJ, Kollermann J, et al. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clin Cancer Res. 2010;16:56\u201364.","journal-title":"Clin Cancer Res"},{"key":"2262_CR51","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1101\/gad.1569307","volume":"21","author":"J Zhang","year":"2007","unstructured":"Zhang J, Harnpicharnchai P, Jakovljevic J, Tang L, Guo Y, Oeffinger M, et al. Assembly factors Rpf2 and Rrs1RRS1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into nascent ribosomes. Genes Dev. 2007;21:2580\u201392.","journal-title":"Genes Dev"},{"key":"2262_CR52","doi-asserted-by":"publisher","first-page":"620925","DOI":"10.3389\/fcell.2021.620925","volume":"9","author":"Y Hua","year":"2021","unstructured":"Hua Y, Song J, Peng C, Wang R, Ma Z, Zhang J, et al. Advances in the relationship between regulator of ribosome synthesis 1 (RRS1RRS1) and diseases. Front Cell Dev Biol. 2021;9:620925.","journal-title":"Front Cell Dev Biol"},{"key":"2262_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41390-022-02073-0","volume":"97","author":"X Zhang","year":"2025","unstructured":"Zhang X, Liu C, Cao Y, Liu L, Sun F, Hou L. RRS1RRS1 knockdown inhibits the proliferation of neuroblastoma cell via PI3K\/Akt\/NF-kappaB pathway. Pediatr Res. 2025;97:202\u201312.","journal-title":"Pediatr Res"},{"key":"2262_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2420437","volume":"2020","author":"X Yan","year":"2020","unstructured":"Yan X, Wu S, Liu Q, Zhang J. RRS1RRS1 promotes retinoblastoma cell proliferation and invasion via activating the AKT\/mTOR signaling pathway. Biomed Res Int. 2020;2020:2420437.","journal-title":"Biomed Res Int"},{"key":"2262_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/geno.1997.4856","volume":"44","author":"EL Germain-Lee","year":"1997","unstructured":"Germain-Lee EL, Obie C, Valle D. NVLNVL: a new member of the AAA family of ATPases localized to the nucleus. Genomics. 1997;44:22\u201334.","journal-title":"Genomics"},{"key":"2262_CR56","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1158\/2159-8290.CD-24-0231","volume":"14","author":"JJ Lin","year":"2024","unstructured":"Lin JJ, Horan JC, Tangpeerachaikul A, Swalduz A, Valdivia A, Johnson ML, et al. NVLNVL-655 is a selective and Brain-Penetrant inhibitor of diverse ALK-Mutant Oncoproteins, including Lorlatinib-Resistant compound mutations. Cancer Discov. 2024;14:2367\u201386.","journal-title":"Cancer Discov"},{"key":"2262_CR57","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/2159-8290.CD-22-0968","volume":"13","author":"A Drilon","year":"2023","unstructured":"Drilon A, Horan JC, Tangpeerachaikul A, Besse B, Ou SI, Gadgeel SM, et al. NVLNVL-520 is a Selective, TRK-Sparing, and Brain-Penetrant inhibitor of ROS1 fusions and secondary resistance mutations. Cancer Discov. 2023;13:598\u2013615.","journal-title":"Cancer Discov"},{"key":"2262_CR58","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.bbrc.2006.06.017","volume":"346","author":"M Nagahama","year":"2006","unstructured":"Nagahama M, Yamazoe T, Hara Y, Tani K, Tsuji A, Tagaya M. The AAA-ATPase NVLNVL2 is a component of pre-ribosomal particles that interacts with the DExD\/H-box RNA helicase DOB1. Biochem Biophys Res Commun. 2006;346:1075\u201382.","journal-title":"Biochem Biophys Res Commun"},{"key":"2262_CR59","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.bbrc.2011.12.101","volume":"417","author":"J Her","year":"2012","unstructured":"Her J, Chung IK. The AAA-ATPase NVLNVL2 is a telomerase component essential for holoenzyme assembly. Biochem Biophys Res Commun. 2012;417:1086\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"2262_CR60","doi-asserted-by":"publisher","first-page":"e2406961121","DOI":"10.1073\/pnas.2406961121","volume":"121","author":"D Zhang","year":"2024","unstructured":"Zhang D, Li B, Xu H, Li J, Ma C, Ge W, et al. Identification of FBLL1FBLL1 as a neuron-specific RNA 2\u2019-O-methyltransferase mediating neuronal differentiation. Proc Natl Acad Sci U S A. 2024;121:e2406961121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2262_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.793582","volume":"13","author":"P Li","year":"2022","unstructured":"Li P, Liu Y, Song R, Zhao L, Yang J, Lu F, et al. RNA 2\u2019-O-methyltransferase fibrillarin facilitates virus entry into macrophages through inhibiting type I interferon response. Front Immunol. 2022;13:793582.","journal-title":"Front Immunol"},{"key":"2262_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03802-z","volume":"20","author":"B Lu","year":"2022","unstructured":"Lu B, Chen X, Liu X, Chen J, Qin H, Chen S, et al. C\/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2\u2019-O-methylation of PARP1. J Transl Med. 2022;20:618.","journal-title":"J Transl Med"},{"key":"2262_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01238-x","volume":"19","author":"SY Wu","year":"2020","unstructured":"Wu SY, Fu T, Jiang YZ, Shao ZM. Natural killer cells in cancer biology and therapy. Mol Cancer. 2020;19:120.","journal-title":"Mol Cancer"},{"key":"2262_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","volume":"11","author":"B Cozar","year":"2021","unstructured":"Cozar B, Greppi M, Carpentier S, Narni-Mancinelli E, Chiossone L, Vivier E. Tumor-infiltrating natural killer cells. Cancer Discov. 2021;11:34\u201344.","journal-title":"Cancer Discov"},{"key":"2262_CR65","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","volume":"34","author":"SM Hochrein","year":"2022","unstructured":"Hochrein SM, Wu H, Eckstein M, Arrigoni L, Herman JS, Schumacher F, et al. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 2022;34:516-32e11.","journal-title":"Cell Metab"},{"key":"2262_CR66","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.eururo.2020.04.058","volume":"78","author":"C Herberts","year":"2020","unstructured":"Herberts C, Murtha AJ, Fu S, Wang G, Schonlau E, Xue H, et al. Activating AKT1 and PIK3CA mutations in metastatic castration-resistant prostate cancer. Eur Urol. 2020;78:834\u201344.","journal-title":"Eur Urol"},{"key":"2262_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40203-023-00145-5","volume":"11","author":"N Prakash","year":"2023","unstructured":"Prakash N. Evaluation of Piperine analogs against prostate cancer targeting AKT1 kinase domain through network Pharmacological analysis. Silico Pharmacol. 2023;11:7.","journal-title":"Silico Pharmacol"},{"key":"2262_CR68","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1158\/1078-0432.CCR-21-1010","volume":"27","author":"Z Tang","year":"2021","unstructured":"Tang Z, Pilie PG, Geng C, Manyam GC, Yang G, Park S, et al. ATR inhibition induces CDK1-SPOP signaling and enhances anti-PD-L1 cytotoxicity in prostate cancer. Clin Cancer Res. 2021;27:4898\u2013909.","journal-title":"Clin Cancer Res"},{"key":"2262_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176007","volume":"957","author":"Y Yu","year":"2023","unstructured":"Yu Y, Huang X, Liang C, Zhang P. Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer. Eur J Pharmacol. 2023;957:176007.","journal-title":"Eur J Pharmacol"},{"key":"2262_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/cells7090133","author":"J Concetti","year":"2018","unstructured":"Concetti J, Wilson CL. NFKB1 and cancer: friend or foe? Cells. 2018. https:\/\/doi.org\/10.3390\/cells7090133.","journal-title":"Cells"},{"key":"2262_CR71","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221007","author":"XF Li","year":"2023","unstructured":"Li XF, Selli C, Zhou HL, Cao J, Wu S, Ma RY, et al. Macrophages promote anti-androgen resistance in prostate cancer bone disease. J Exp Med. 2023. https:\/\/doi.org\/10.1084\/jem.20221007.","journal-title":"J Exp Med"},{"key":"2262_CR72","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41418-024-01282-w","volume":"31","author":"D Ren","year":"2024","unstructured":"Ren D, Li W, Zeng R, Liu X, Liang H, Xiong W, et al. Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer. Cell Death Differ. 2024;31:592\u2013604.","journal-title":"Cell Death Differ"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02262-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02262-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02262-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:01:48Z","timestamp":1766152908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-025-02262-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2262"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02262-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6830289\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the Helsinki Declaration and has been approved by the Ethics Review Committee of The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China (medical review no. 291 in 2024). All participants provided their informed consent by signing the necessary forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}